Effects of long-term administration of carprofen on healing of a tibial osteotomy in dogs

American Journal of Veterinary Research

Volumn 72, Issue 5, 2011, Pages 634-641

  Ochi, Hiroki ^a   Hara, Yasushi ^a   Asou, Yoshinori ^b   Harada, Yasuji ^a   Nezu, Yoshinori ^a   Yogo, Takuya ^a   Shinomiya, Kenichi ^b   Tagawa, Masahiro ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE RADIOGRAPHY; CALLUS; CARTILAGE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; INTRAMEDULLARY NAILING; LONG TERM CARE; NONHUMAN; RIGIDITY; TIBIA OSTEOTOMY;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMECHANICS; CARBAZOLES; DOGS; FEMALE; FRACTURE HEALING; HINDLIMB; OSTEOTOMY; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 79955747888     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.5.634     Document Type: Article

References (46)

1. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;355:S7-S21.
2. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005;36:1392-1404.
3. Schindeler A, McDonald MM, Bokko P, et al. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 2008;19:459-466.
4. Raisz LG, Lorenzo JA. Prostaglandins and proinflammatory cytokines. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of bone and cartilage metabolism: principles and clinical applications. 2nd ed. New York: Academic Press Inc, 2006;115-128.
5. Raisz LG. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 1999;7:419-421.
6. Krischak GD, Augat P, Blakytny R, et al. The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteo blasts in bone defect healing in rats. Arch Orthop Trauma Surg 2007;127:453-458.
7. Kawaguchi H, Pilbeam CC, Harrison JR, et al. The role of pros-taglandins in the regulation of bone metabolism. Clin Orthop Relat Res 1995;313:36-46.
8. Paralkar VM, Borovecki F, Ke HZ, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A 2003;100:6736-6740.
9. Shih MS, Norridin RW. Effects of prostaglandins on regional remodeling changes during tibial healing in beagles: a histomorphometric study. Calcif Tissue Int 1986;39:191-197.
10. Shih MS, Norrdin RW. Effect of prostaglandin E2 on rib fracture healing in Beagles: histomorphometric study on periosteum adjacent to the fracture site. Am J Vet Res 1986;47:1561-1564.
11. Li XJ, Jee WS, Li YL, et al. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs. Bone 1990;11:353-364.
12. Li M, Ke HZ, Qi H, et al. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003;18:2033-2042.
13. Tsatsanis C, Androulidaki A, Venihaki M, et al. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 2006;38:1654-1661.
14. Fracon RN, Teofilo JM, Satin RB, et al. Prostaglandins and bone: potential risks and benefits related to the use of nonsteroidal anti-inflammatory drugs in clinical dentistry. J Oral Sci 2008;50:247-252.
15. Hikiji H, Takato T, Shimizu T, et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog Lipid Res 2008;47:107-126.
16. Li L, Pettit AR, Gregory LS, et al. Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name. Cytokine Growth Factor Rev 2006;17:203-216.
17. Clark TP. The clinical pharmacology of cyclooxygenase-2-selective and dual inhibitors. Vet Clin North Am Small Anim Pract 2006;36:1061-1085.
18. Papich MG. An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals. Vet Clin North Am Small Anim Pract 2008;38:1243-1266.
19. Sudmann E, Dregelid E, Bessesen A, et al. Inhibition of fracture healing by indomethacin in rats. Eur J Clin Invest 1979;9:333-339.
20. Huo MH, Troiano NW, Pelker RR, et al. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histo-logic, and histomorphometric parameters in rats. J Orthop Res 1991;9:383-390.
21. Altman RD, Latta LL, Keer R, et al. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 1995;9:392-400.
22. Krischak GD, Augat P, Sorg T, et al. Effects of diclofenac on periosteal callus maturation in osteotomy healing in an animal model. Arch Orthop Trauma Surg 2007;127:3-9.
23. Beck A, Krischak G, Sorg T, et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003;123:327-332.
24. Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670-675.
25. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am 2007;89:114-125.
26. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002;17:963-976.
27. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop 2005;76:470-474.
28. Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-1415.
29. Houlton JE, Dunning D. Preoperative patient management. In: Johnson AL, Houlton JE, Vannini RV, eds. AO principles of fracture management in the dog and cat. New York: Thieme, 2006;1-25.
30. Atilola M, Sumner SG. Nonunion fractures in dogs. J Vet Orthop 1984;3:21-24.
31. Hunt JM, Aitken ML, Denny HR, et al. The complications of diaphyseal fractures in dogs: a review of 100 cases. J Small Anim Pract 1980;21:103-119.
32. Sumner-Smith G. A comparative investigation into the healing of fractures in miniature poodles and mongrel dogs. J Small Anim Pract 1974;15:323-328.
33. Hara Y, Nakamura T, Fukuda H, et al. Changes of biomechanical characteristics of the bone in experimental tibial osteotomy model in the dog. J Vet Med Sci 2003;65:103-107.
34. Nakamura T, Hara Y, Tagawa M, et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 1998;13:942-949.
35. Edwards RB III, Seeherman HJ, Bogdanske JJ, et al. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J Bone Joint Surg Am 2004;86:1425-1438.
36. Manabe T, Mori S, Mashiba T, et al. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 2007;40:1475-1482.
37. Piermattei DL, Flo GL, DeCamp CE. Fractures: classifications, diagnosis, and treatment. In: Piermattei DL, Flo GL, DeCamp CE, eds. Handbook of small animal orthopedics and fracture repair. 4th ed. Philadelphia: Saunders, 2006;25-159.
38. Griffon DJ. Fracture healing. In: Johnson AL, Houlton JE, Vannini RV, eds. AO principles of fracture management in the dog and cat. New York: Thieme, 2006;73-98.
39. Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J Bone Joint Surg Am 2006;88(suppl 3):140-147.
40. Pelletier JP, Lajeunesse D, Jovanovic DV, et al. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 2000;27:2893-2902.
41. Kawaguchi H. Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process. J Bone Miner Res 2009;24:8-11.
42. Rovesti GL. Complications of fracture treatment. In: Johnson AL, Houlton JE, Vannini RV, eds. AO principles of fracture management in the dog and cat. New York: Thieme, 2006;394-433.
43. Piermattei DL, Flo GL, DeCamp CE. Delayed union and non-union. In: Piermattei DL, Flo GL, DeCamp CE, eds. Handbook of small animal orthopedics and fracture repair. 4th ed. Philadelphia: Saunders, 2006;168-175.
44. Tshamala M, van Bree H, Mattheeuws D. Biomechanical properties of etyulene oxide sterilized and cryopreserved cortical bone allografts. Vet Comp Orthop Traumatol 1994;7:25-30.
45. Kemp TJ, Bachus KN, Nairn JA, et al. Functional trade-offs in the limb bones of dogs selected for running versus fighting. J Exp Biol 2005;208:3475-3482.
46. Heiner DE, Meyer MH, Frick SL, et al. Gene expression during fracture healing in rats comparing intramedullary fixation to plate fixation by DNA microarray. J Orthop Trauma 2006;20:27-38